GeoVax Labs, Inc. New (GOVX) is a publicly traded Healthcare sector company. As of August 28, 2026, GOVX trades at $0.58 with a market cap of $3.74M and a P/E ratio of -0.03. GOVX moved +0.35% today. Year to date, GOVX is -86.07%; over the trailing twelve months it is -96.13%. Its 52-week range spans $0.59 to $67.75. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces GOVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover GOVX: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $10.00.
| Metric | Value |
|---|---|
| Price | $0.58 |
| Market Cap | $3.74M |
| P/E Ratio | -0.03 |
| EPS | $-22.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $67.75 |
| 52-Week Low | $0.59 |
| Volume | 106.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.49M |
| Net Income | $-21.46M |
| Gross Margin | 0.00% |
2 analysts cover GOVX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.